Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia | Zendy

Gül Ruhsar YILMAZ | Zendy; Tümer Güven | Zendy; Rahmet Güner | Zendy; Zeliha Koçak Tufan | Zendy; Şeval İzdeş | Zendy; Mehmet A. Taşyaran | Zendy; Ziya Cibali Açıkgöz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia

Author(s) -

Gül Ruhsar YILMAZ,

Tümer Güven,

Rahmet Güner,

Zeliha Koçak Tufan,

Şeval İzdeş,

Mehmet A. Taşyaran,

Ziya Cibali Açıkgöz

Publication year - 2015

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.6195

Subject(s) - colistin , ventilator associated pneumonia , sulbactam , medicine , carbapenem , acinetobacter baumannii , pneumonia , intensive care medicine , microbiology and biotechnology , antibiotics , pseudomonas aeruginosa , biology , imipenem , bacteria , antibiotic resistance , genetics

Colistin use has increased over the last ten years because of multidrug-resistant microorganisms. The aim of this study was to compare the clinical and microbiological efficacy of colistin alone or in combination with sulbactam or carbapenem in the treatment of ventilator-associated pneumonia (VAP) due to multidrug-resistant (MDR) and extremely drug-resistant (XDR) A. baumannii.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research